Next Generation News and Research

RSS

Researchers conduct experiments comparing de novo proteins with computer-generated proteins

Proteins are components of every cell. How they have changed in the course of evolution for the purpose of taking on new functions in the body, has long been a subject of research.

12 Apr 2023

Study finds mobile antibiotic resistance genes in some probiotic bacteria, raising concerns for public health

Researchers examine antibiotic resistance genes and their mobility in Bifidobacteriales and Lactobacillales species.

11 Apr 2023

Study to measure the impact of whole genome sequencing in patients with cardiovascular disease

Henry Ford Health research teams are launching a series of clinical studies in partnership with Illumina Inc., a global leader in DNA sequencing and array-based technologies, to assess the impact of comprehensive genomic testing in various disease areas.

11 Apr 2023

Study reveals substantial decline in alcohol screening rates during the first COVID-19 surge

New research from Boston Medical Center found that alcohol screening rates dropped substantially during the first COVID-19 surge. Published in Preventive Medicine Reports, the study highlights that during the COVID-19 pandemic, there were increases in unhealthy alcohol consumption and alcohol related morbidity and mortality.

10 Apr 2023

Innovative statewide surveillance system will help reduce the burden of opioid use disorder in Kentucky

University of Kentucky researchers are creating an innovative statewide surveillance system to inform prevention and response efforts aimed at reducing the burden of opioid use disorder in Kentucky.

10 Apr 2023

DPE analysis may help improve the diagnosis and management of colorectal cancer

A new editorial paper was published in Oncoscience (Volume 10) on March 23, 2023, entitled, "New method of clustering colorectal cancer patients using differential presence of exons (DPE) sequencing."

7 Apr 2023

Newly discovered antibody appears to block infection by all dominant variants of SARS-CoV-2 virus

A team led by researchers at Weill Cornell Medicine, the University of Wisconsin-Madison; Scripps Research and the University of Chicago has identified an antibody that appears to block infection by all dominant variants of the virus that causes COVID-19, including Omicron, the most recent.

7 Apr 2023

$1 million NIH grant to support UTEP's transformative pancreatic cancer research

The University of Texas at El Paso will undertake potentially transformative research on how specific risk factors promote pancreatic cancer development with support from a $1 million grant from the National Institutes of Health's National Cancer Institute.

6 Apr 2023

Omicron BA.5 variant demonstrates increased neuroinvasiveness and pathogenicity in mice

Researchers assessed the extent of SARS-CoV-2 Omicron VOC BA.5 sub-VOC infection-associated brain infection and death.

5 Apr 2023

Novel molecule may help overcome the devastating symptoms of Duchenne muscular dystrophy

In a new study published in The FASEB Journal, investigators demonstrated the potential of a molecule that may help overcome some of the devastating symptoms of Duchenne muscular dystrophy (DMD), the most common life-limiting congenital neuromuscular disorder.

5 Apr 2023

Clinical trial may change the paradigm of care for patients with ALK-driven high-risk neuroblastoma

In a significant step for the treatment of neuroblastoma, an international group of researchers led by Children's Hospital of Philadelphia (CHOP), Winship Cancer Institute of Emory University and the New Approaches to Neuroblastoma Therapy (NANT) Consortium has shown that the targeted therapy lorlatinib is safe and effective in treating high-risk neuroblastoma.

4 Apr 2023

MIP Discovery announces drugs of abuse reagent launch

MIP Discovery, a leader in rationally designed detection reagents based on its proprietary nanoMIP technology, in response to the growing synthetic opioid crisis has announced the launch of its first drugs of abuse products which are able to recognize norfentanyl, the main urinary metabolite of fentanyl.

From MIP Discovery 4 Apr 2023

Study identifies ultra-broad SARS-CoV-2 neutralizing antibodies that target various spike epitopes

Researchers screened the circulating B lymphocyte repertoires of coronavirus disease 2019 convalescents and vaccines using multiplexed antigen panels.

3 Apr 2023

A novel species of dependoparvovirus has been identified in monk parakeets in Madrid

A novel dependoparvovirus identified from 28 healthy monk parakeets from urban regions of Spain.

30 Mar 2023

Mouse avatars could help design more effective and personalized therapies for multiple myeloma

An international group of researchers, led by Dr. José Ángel Martínez-Climent at the Cima University of Navarra, has created mouse avatars of patients with multiple myeloma to study and develop personalized treatments against this blood cancer, the second most frequent hematological cancer and incurable in most cases.

29 Mar 2023

Experimental anti-obesity drug may control appetite without surgery or nausea

Imagine getting the benefits of gastric bypass surgery without going under the knife - a new class of compounds could do just that. In lab animals, these potential treatments reduce weight dramatically and lower blood glucose.

29 Mar 2023

The emergence of lateral flow assays in diagnostics

In this interview, News-Medical talks to Hasret Altan-Martin from Sartorius about the ongoing emergence of lateral flow assays in diagnostics.

From Sartorius Lab Instruments GmbH & Co. KG 29 Mar 2023

Next-generation influenza vaccines show greater impact and cost-effectiveness, study suggests

In a recent study published in the BMC Medicine Journal, researchers conducted a modeling study to evaluate the cost-effectiveness and health impacts of the next-generation vaccines against influenza in Kenya.

28 Mar 2023

Two distinct subtypes of insulin-producing beta cells identified

A team led by Van Andel Institute and Max Planck Institute of Immunobiology and Epigenetics scientists has identified two distinct subtypes of insulin-producing beta cells, or ß cells, each with crucial characteristics that may be leveraged to better understand and treat Type 1 and Type 2 diabetes.

28 Mar 2023

New molecule slows the effects of one of SARS-CoV-2's more dangerous components

Researchers have designed a molecule that slows the effects of one of SARS-CoV-2's more dangerous components – an enzyme called a protease that cuts off the immune system's communications and helps the virus replicate.

28 Mar 2023

Next Generation News and Research

Researchers conduct experiments comparing de novo proteins with computer-generated proteins

Study finds mobile antibiotic resistance genes in some probiotic bacteria, raising concerns for public health

Study to measure the impact of whole genome sequencing in patients with cardiovascular disease

Study reveals substantial decline in alcohol screening rates during the first COVID-19 surge

Innovative statewide surveillance system will help reduce the burden of opioid use disorder in Kentucky

DPE analysis may help improve the diagnosis and management of colorectal cancer

Newly discovered antibody appears to block infection by all dominant variants of SARS-CoV-2 virus

$1 million NIH grant to support UTEP's transformative pancreatic cancer research

Omicron BA.5 variant demonstrates increased neuroinvasiveness and pathogenicity in mice

Novel molecule may help overcome the devastating symptoms of Duchenne muscular dystrophy

Clinical trial may change the paradigm of care for patients with ALK-driven high-risk neuroblastoma

MIP Discovery announces drugs of abuse reagent launch

Study identifies ultra-broad SARS-CoV-2 neutralizing antibodies that target various spike epitopes

A novel species of dependoparvovirus has been identified in monk parakeets in Madrid

Mouse avatars could help design more effective and personalized therapies for multiple myeloma

Experimental anti-obesity drug may control appetite without surgery or nausea

The emergence of lateral flow assays in diagnostics

Next-generation influenza vaccines show greater impact and cost-effectiveness, study suggests

Two distinct subtypes of insulin-producing beta cells identified

New molecule slows the effects of one of SARS-CoV-2's more dangerous components

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News